# OnCo record ian-tannock (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/ian-tannock/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "ian-tannock" ;
  schema:name "Ian F. Tannock"@en ;
  schema:description "Led TAX 327, which made docetaxel the first life-extending chemotherapy for prostate cancer, and has spent decades pressing for higher trial standards."@en ;
  schema:url <https://onco.cc/people/ian-tannock/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Tannock%20IF%5BAuthor%5D%20prostate%20docetaxel%20OR%20clinical%20benefit> ;
  onco:tag "evidence", "methodology", "prostate" ;
  schema:jobTitle "Emeritus Professor of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:drugs <https://onco.cc/drugs/docetaxel/> ;
  onco:institutions <https://onco.cc/institutions/princess-margaret/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-prasad-surrogate-endpoints-jama-im-2015/>, <https://onco.cc/key-papers/paper-drug-dosing-conundrum-nejm-2021/> ;
  schema:affiliation <https://onco.cc/institutions/princess-margaret/> .